Back
ProPhase Labs Vs. OncoCyte Industry Stock Comparison
Sell
11
PRPH
ProPhase Labs
Last Price:
$0.65
Seasonality Move:
4.58%
Sell
20
OCX
OncoCyte
Last Price:
$2.24
Seasonality Move:
16.26%
Sell
11
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy, Sell or Hold?
-
The current ProPhase Labs [PRPH] share price is $0.65. The Score for PRPH is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
PRPH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
PRPH Stock Price Chart
What is ProPhase Labs's stock price today?
-
The ProPhase Labs share price today is $0.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing selling pressure, which indicates risk of future bearish movement.
OCX Stock Price Chart
PRPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 26.42 | Sell |
Chaikin Money Flow: | -77260 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.68 - 0.78) | Sell |
Bollinger Bands (100): | (1.15 - 2.79) | Sell |
OCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 30.62 | Sell |
Chaikin Money Flow: | -55338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.3 - 2.64) | Sell |
Bollinger Bands (100): | (2.62 - 3.18) | Sell |
PRPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.67 | Sell |
20-day SMA: | 0.72 | Sell |
50-day SMA: | 1.37 | Sell |
200-day SMA: | 3.42 | Sell |
8-day EMA: | 0.68 | Sell |
20-day EMA: | 0.79 | Sell |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 2.95 | Sell |
OCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Sell |
20-day SMA: | 2.42 | Sell |
50-day SMA: | 2.75 | Sell |
200-day SMA: | 2.89 | Sell |
8-day EMA: | 2.29 | Sell |
20-day EMA: | 2.42 | Sell |
50-day EMA: | 2.64 | Sell |
200-day EMA: | 3.07 | Sell |
ProPhase Labs Earnings Growth & PRPH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and an increase next year of $0.43 per share.
OncoCyte Earnings Growth & OCX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
ProPhase Labs Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
OncoCyte Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |